March 18, 2021 -- PerkinElmer has inked a collaboration with Insightful Science through which it will expand its documentation, workflow, and decision-making Signals informatics platform to expand its offerings in biologics drug discovery.
Under the agreement, PerkinElmer's Signals platform will be combined with Insightful Science's cloud-based SnapGene and Geneious Prime software, both of which help molecular biologists accomplish DNA construct design and molecular cloning. The combined offering will allow users to access and compare data across experiments and instruments, PerkinElmer said.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
